HeartMate 3 in a ccTGA patient
Daniel E. Clark(Stanford University), Jonathan N. Menachem(Vanderbilt University Medical Center), Bret A. Mettler(Vanderbilt University Medical Center), Matthew Danter(Vanderbilt University Medical Center), Ryan Byrne(Monroe Carell Jr. Children's Hospital), Sandip Zalawadiya(Vanderbilt University Medical Center), Benjamin P. Frischhertz(Vanderbilt University Medical Center), Rachel Klausner(Vanderbilt University Medical Center), Tadarro L. Richardson(Vanderbilt University Medical Center)
Cited by 4
Related Papers
Results of the FUEL Trial
|Circulation|2019|160
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation
|Journal of the American College of Cardiology|2023|79
COVID-19 in Adults With Congenital Heart Disease
|Journal of the American College of Cardiology|2021|76
Advanced Heart Failure in Adults With Congenital Heart Disease
|JACC Heart Failure|2019|63
Center volume and post-transplant survival among adults with congenital heart disease
|The Journal of Heart and Lung Transplantation|2018|61